Healthcare >> Analyst Interviews >> March 19, 2012
Diversified Companies Expected to Outperform Sector-Specific Names in Med Tech – Joanne K. Wuensch – BMO Capital Markets
Joanne K. Wuensch is a Research Analyst in the equity research group at BMO Capital Markets Corp., where she covers medical technology companies in the cardiology, ophthalmology, orthopedic and respiratory sectors. Before joining BMO Capital Markets, she was a Research Analyst with ABN Amro Group, formerly ING Barings, where she covered medical products, as well as a Research Associate in the medical technology group at UBS Securities. Her career in financial services began at J.P. Morgan, where, among other positions, she was an Associate in municipal finance investment banking in the health care and higher education group. Ms. Wuensch joined BMO Capital Markets in 2002. She holds an MPA degree from New York University and a B.A. from the University of Delaware. Profile
TWST: Where do you focus your attention in the medical device space?
Ms. Wuensch: Of the 19 names in our coverage, we have four large-cap names that we're recommending, and one small-cap name. We're